subject: FDA warns of prostate cancer drug risks [print this page] The FDA said in May it was reviewing six studies that showed a small increased risk of diabetes or heart disease in patients treated with the drugs when compared with other prostate cancer therapies.
FDA warns of prostate cancer drug risks
By: alam.md
Zaproxy alias impedit expedita quisquam pariatur exercitationem. Nemo rerum eveniet dolores rem quia dignissimos.
